2021
The Birth of Naloxone: An Intellectual History of an Ambivalent Opioid
Kolbe L, Fins J. The Birth of Naloxone: An Intellectual History of an Ambivalent Opioid. Cambridge Quarterly Of Healthcare Ethics 2021, 30: 637-650. PMID: 34702407, DOI: 10.1017/s0963180121000116.Peer-Reviewed Original Research
2013
Error and Bias in the Evaluation of Prescription Opioid Misuse: Should the FDA Regulate Clinical Assessment Tools?
Meltzer E, Hall W, Fins J. Error and Bias in the Evaluation of Prescription Opioid Misuse: Should the FDA Regulate Clinical Assessment Tools? Pain Medicine 2013, 14: 982-987. PMID: 23594383, DOI: 10.1111/pme.12099.Peer-Reviewed Original ResearchConceptsFood and Drug AdministrationClinical assessment toolScreening toolAssessment toolOpioid-related aberrant behaviorsAberrant medication-related behaviorsOpioid-related risksChronic opioid therapyPrescription opioid misusePredictive of addictionMedication-related behaviorsOpioid therapyPain medicationStandardized questionnaireOpioid misuseIdentified patientsAt-riskDrug AdministrationDiagnose illnessAddictive disordersPatientsAberrant behaviorScreeningComprehensive planAddiction
2011
A True Believer’s Flawed Analysis
Foley K, Fins J, Inturrisi C. A True Believer’s Flawed Analysis. JAMA Internal Medicine 2011, 171: 867-868. PMID: 21555672, DOI: 10.1001/archinternmed.2011.166.Peer-Reviewed Original Research
1997
Letters to the Editor
Fins J, Miller F. Letters to the Editor. Journal Of Palliative Care 1997, 13: 52-52. PMID: 9105159, DOI: 10.1177/082585979701300110.Peer-Reviewed Original Research